To determine whether the PSCs derived Galectin-1 induced the proliferative activity of pancreatic cancer cells, we analyzed the S-phase fraction (SPF) of CFPAC-1 by flow cytometry, and the percentages of cells in Apoptosis, G1, S, and G2 were quantified. The gene discussed is LGALS1; the disease is pancreatic neoplasm.